| Pharmaceutical active ingredients: |
| FurosemideSpironolactone |
| Available forms, composition and doses of Osyrol Lasix: |
| Capsules; Oral; Furosemide 20 mg; Spironolactone 100 mgCapsules; Oral; Furosemide 20 mg; Spironolactone 50 mg |
| Osyrol Lasix medical category: |
| Human:Diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03DA01 - SpironolactoneC03EB01 - Furosemide and potassium-sparing agents |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lasilacton | Furosemide; Spironolactone | Sanofi-Aventis |
| Lasilactona | Furosemide; Spironolactone | Sanofi-Aventis |
| Lasilactone | Furosemide; Spironolactone | Sanofi-Aventis; Borg Medicare |
| Lasitone | Furosemide; Spironolactone | Sanofi-Aventis |
| Minilactone | Furosemide; Spironolactone | RPG Life Sciences |
| Spiro Comp. | Furosemide; Spironolactone | Ratiopharm |
| Spiro Comp. Forte | Furosemide; Spironolactone | Ratiopharm |
| Spiro Compositum | Furosemide; Spironolactone | Ratiopharm |
| Spiro-D | Furosemide; Spironolactone | Lichtenstein Pharmazeutica |
| Spiro-D-Tablinen | Furosemide; Spironolactone | Lichtenstein Pharmazeutica |